When Dr. Thomas Durcan, director of The Neuro’s Early Drug Discovery Unit (EDDU), found out his team had been awarded a 2022 Discovery Grant, “It was a very happy day for us all.”
Dr. Richard Robitaille, at the Université de Montréal, received his first grant from ALS Canada ten years ago. Already a world-leading expert on the neuromuscular junction (NMJ), the funding was his first research foray into ALS and allowed him to find clinical applications for his expertise. His lab now spends nearly all their research efforts on the disease.
For years, interior designer Raija Hilska felt like she was “always dragging something along”. Deep melancholy, profound sadness, raw emotions and, sometimes, thoughts of suicide.
When I was diagnosed with autism at 13 years old, I wasn’t even sure what the word meant. My parents told me, in the most basic way, that my brain worked differently than others. It was not good or bad, it was just different.
